Activation markers associated with terminal differentiation (CD57) and cell proliferative capacity and memory phenotypes (CD27 and CD28) were measured given their prognostic value in literature characterizing tumor-infiltrating lymphocytes (TIL; refs. 24, 25). The gene discussed is CD27; the disease is neoplasm.